Crohn’s & Colitis UK briefs TVC to promote WALK IT 2017
Crohn’s & Colitis UK, the UK charity which supports people suffering from colitis or Crohn’s disease, has brought TVC Group on board to promote WALK IT 2017, a nationwide walks programme to raise awareness and funds.
According to the charity, every 30 minutes, someone in the UK is diagnosed with Crohn’s disease or ulcerative colitis, the two main forms of Inflammatory Bowel Disease (IBD) and WALK IT 2017 is designed to raise awareness of IBD and help reduce the stigma, fear and isolation experienced by those affected.
Eight routes of 5km and 10km will be rolled out across the country in May, June and July next year.
TVC, which won the brief following a competitive pitch, will develop an integrated PR, marketing and comms strategy to support the programme.
The agency’s campaign aims to position Crohn’s & Colitis UK as the leading UK charity within the IBD sphere, as well as raise funds to support its mission to help people with the conditions.
Sam Afhim, director of income generation at Crohn’s & Colitis UK, said: “WALK IT is one of our biggest fundraising drives of the year and we wanted a PR and marketing partner to help spread the message far and wide.
“Chronic conditions like Crohn’s disease and ulcerative colitis are becoming more common, especially among young people, and the impact on work, social and family life can be devastating.
“At least 300,000 people in the UK have been diagnosed with Crohn’s disease and ulcerative colitis, but we think the number of people living with the condition is more than double this. The awareness and funds we’ll raise from WALK IT 2017 are crucial to help us beat these lifelong conditions.”
James Myers, group MD at TVC Group, said: “We’re thrilled to win this brief. TVC has a rich heritage in supporting charitable causes and helping them raise awareness for their campaigns. We hope we can help inspire a whole new community of people to get walking and make WALK IT 2017 bigger, better and even more successful than last year.”